Trials / Completed
CompletedNCT06121609
ED90 of Remimazolam Anesthesia Induction in Painless Bidirectional Endoscopy in Children
The 90% Effective Dose (ED90) of Remimazolam Anesthesia Induction in Painless Bidirectional Endoscopy in Children: a Biased Coin up and Down Sequential Trial
- Status
- Completed
- Phase
- N/A
- Study type
- Interventional
- Enrollment
- 165 (actual)
- Sponsor
- Tongji Hospital · Academic / Other
- Sex
- All
- Age
- 12 Years
- Healthy volunteers
- Not accepted
Summary
Exploring the ED90 of remimazolam in pediatric bidirectional endoscopy at different age groups.
Detailed description
Exploring the ED90 of remimazolam in pediatric bidirectional endoscopy at different age groups, providing a more scientific clinical dose selection basis for the anesthesia induction application of Remazolam.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DRUG | Remimazolam | Exploring ED90 induced by remimazolam anesthesia in children of different age groups undergoing painless bidirectional endoscopy |
Timeline
- Start date
- 2024-01-15
- Primary completion
- 2024-04-30
- Completion
- 2024-04-30
- First posted
- 2023-11-08
- Last updated
- 2025-12-02
- Results posted
- 2025-12-02
Locations
1 site across 1 country: China
Source: ClinicalTrials.gov record NCT06121609. Inclusion in this directory is not an endorsement.